Sensulin
PrivateLast Round
Series A
Dec 16, 2021
Total Funding Raised
$4.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sensulin operates in Healthcare & Life Sciences and is based in Oklahoma City, Oklahoma. Its latest recorded funding round was a Series A round in December 2021.
Sensulin is a biopharmaceutical company that is developing a glucose-responsive insulin for type 1 and type 2 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Clinical Trials
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sensulin Comparables
Compare Sensulin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thermalin Diabetes | 81% | |
| Zenomics, Inc. | 76% | |
| Merck & Co., Inc. | 76% |
For institutional investors. Book with your work email.
Sensulin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 16, 2021 | ||||
| VC Round | May 25, 2018 | ||||
| Grant | Dec 1, 2013 | ||||
| Seed | Feb 1, 2013 | ||||
| Grant | Sep 1, 2009 |
For institutional investors. Book with your work email.
Sensulin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| StartUp Health | Series A |
| Cortado Ventures | Series A |
| National Science Foundation | Grant |
| AngelMD | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2026
Monthly visitors grew 121% MoM, reaching 3.3K.
- Apr 18, 2026
Monthly visitors grew 68% MoM, reaching 5.4K.
For institutional investors. Book with your work email.
Sensulin Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sensulin's valuation, stock price, and market status.
Is Sensulin a public or private company?
Sensulin is a private company.
What is the current stock price of Sensulin?
Sensulin is a private company, so its shares have no public market price. Caplight tracks Sensulin's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sensulin worth (valuation)?
Valuation information for Sensulin is not publicly available.
Can I buy Sensulin stock?
Sensulin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sensulin's last funding round?
Sensulin's most recent funding round was Series A on December 16, 2021.
Who are the main investors in Sensulin?
Key investors in Sensulin include National Institute of Diabetes and Digestive and Kidney Diseases, StartUp Health, Cortado Ventures, National Science Foundation, AngelMD.
Will Sensulin IPO soon?
No public IPO plans have been announced for Sensulin.
How can I track Sensulin secondary market activity?
Caplight tracks bids, offers, and trades in Sensulin's shares on secondary markets.